Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scilex Holding (SCLX) Cash & Equivalents (2020 - 2025)

Scilex Holding (SCLX) has 6 years of Cash & Equivalents data on record, last reported at $900000.0 in Q3 2025.

  • For Q3 2025, Cash & Equivalents rose 800.0% year-over-year to $900000.0; the TTM value through Sep 2025 reached $900000.0, up 800.0%, while the annual FY2024 figure was $3.3 million, 16.55% down from the prior year.
  • Cash & Equivalents reached $900000.0 in Q3 2025 per SCLX's latest filing, down from $4.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $34.1 million in Q2 2023 and bottomed at $34961.0 in Q3 2022.
  • Average Cash & Equivalents over 5 years is $4.0 million, with a median of $2.0 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 14117.82% in 2021, then tumbled 94.88% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $4.3 million in 2021, then plummeted by 49.65% to $2.2 million in 2022, then surged by 79.53% to $3.9 million in 2023, then dropped by 16.55% to $3.3 million in 2024, then tumbled by 72.49% to $900000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $900000.0 in Q3 2025, $4.1 million in Q2 2025, and $5.8 million in Q1 2025.